Advantage of endoscopic mucosal resection with a cap for rectal neuroendocrine tumors

Table 1 Baseline patient characteristics n (%)

	EMR-C(n = 65)	ESD(n = 51)	P value
Age (yr), mean ± SD	52.31 ± 9.83	48.47 ± 12.23	0.063
Male gender	43 (66.2)	33 (64.7)	0.872
Follow up period (d), mean ± SD	689.58 ± 468.94	760.84 ± 458.91	0.414
Specimen size (mm),	10.15 ± 2.21	13.10 ± 3.99	< 0.001
mean ± SD (range)	(6.0-15.0)	(8.0-25.0)
Tumor size (mm),	4.62 ± 1.66	7.73 ± 3.14	< 0.001
mean ± SD (range)	(1.0-10.0)	(3.0-18.0)
EUS measured size (mm),	4.72 ± 1.51	7.27 ± 2.54	< 0.001
mean ± SD (range)	(1.0-8.0)	(2.7-17.0)
Tumor size (mm)
0 < tumor size ≤ 5	50	13
5 < tumor size ≤ 10	15	31
> 10	0	7

EMR-C: Endoscopic mucosal resection with a cap; ESD: Endoscopic submucosal dissection.